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TECHNICAL NOTE
Validation of inulin as a marker for glomerular filtration in
preterm babies
MALCOLM G. COULTHARD and VALERIE RUDDOCK
The Department of Child Health, University of Newcastle upon Tyne, Newcastle upon Tyne, England
Inulin, a vegetable fructose polymer with an average molecu-
lar weight of 5000, has long been regarded as the 'gold standard'
for measuring glomerular filtration. However, comparisons
between the clearance of inulin and that of other markers have
led to the hypothesis that glomerular pore size is related to body
size, and that inulin may not be freely filtered in some small
mammals [1]. Similar conclusions may be reached from data on
estimated glomerular pore size in young children calculated
from dextran clearances [2], but the serious limitations of such
an approach are well documented [31 Studies of inulin handling
in fetal lambs [4] and rats by glomerular micropuncture [5] have
failed to confirm any restriction to filtration, but no direct
evidence is available in man. We therefore used gel chromatog-
raphy to assess whether or not higher molecular weight inulin
accumulated in the plasma of very immature babies who were
infused with inulin for several days.
Methods. Five preterm babies (Table 1) were infused contin-
uously with inulin from the first day of life as part of a study of
renal function in babies which had the approval of Newcastle
Health Authority Ethical Committee. Informed parental con-
sent was obtained for each patient. The solution of 25 mg/mI
inulin (Kerfoot) in water was infused using a syringe pump
through peripheral lines which had been erected for clinical
reasons. All the babies were stable when studied, although
three required a period of artificial ventilation for hyaline
membrane disease; two of the three babies died later of
septicemia. Small samples of blood and urine were taken daily
to assess renal function. A larger aliquot of urine and 1 ml of
heparinized blood from a free-flowing heel stick were obtained
for chromatography just before the infusion was discontinued,
and in three patients a further blood sample was taken 10 to 15
hr later. The plasma was separated immediately and all the
specimens were then stored at —20°C.
Ge/filtration chromatography. G50 superfine sephadex was
eluted with 0.1 M phosphate buffer containing 0.002% chlorexi-
dine at pH 7 in a 600 x 9 mm column at 4 ml/hr, and 0.62 ml
fractions were collected using a drop counter. The column
characteristics were checked between inulin studies using dex-
tran blue to mark the void volume and para-amminohippurate
(PAH) as the low molecular weight marker for the bed volume;
the peak of the curve was always in fraction 27 for dextran blue
and fraction 68 for PAH. In most study runs 200 g of inulin
from the sample were loaded along with 6 sg (0.01 Ci) of 4C-
inulin and 400 g of PAH. Dextran blue was omitted because it
interfered with the inulin assay. However, only 27 to 44 tg of
unlabelled inulin were present in the postinfusion plasma
samples.
Plasma was deproteinated with 10% trichioroacetic acid, and
the supernatant was adjusted immediately to pH 7 using 5 ivi
NaOH and 1 M phosphate buffer. Although this brief acid
exposure did not affect the inulin molecular weight profile,
aqueous samples and urine were treated similarly to ensure
identical conditions. Inulin was measured in triplicate by the
resorcinol-thiourea method [6] on 10-pd samples. '4C-inulin was
counted for 5 mm after the addition of 350 pd of the fraction and
250 d of water to 5 ml of scintillant (Liquid Scintillation
Cocktail-T, BDH).
Chromatography was also performed on polyfructosan-S, a
smaller vegetable fructose polymer available for use as an inulin
substitute.
High molecular weight inulin. Chromatography was per-
formed with 10 mg of inulin to prepare fractions containing
relatively high and low molecular weight inulins that could be
resolved clearly into separate peaks when combined and re-run.
The high molecular weight inulin was then added to natural
inulin to produce mixtures containing 5, 10, 15 and 50% of this
fraction. Chromatography was performed to determine whether
or not the mixtures could be distinguished from the original
inulin.
The high molecular weight inulin curve peaked in fraction 33,
where the 14C-inulin curve was at 20% of its peak height. The
shape of each of the other inulin curves was assessed by
subtracting the height of the labelled inulin curve ('4C) from that
of the sample curve (S) at this point, with the height of each
curve expressed as a percentage of its peak height (S-14C).
Results. The broad chromatogram peak for the natural inulin
curve always lay over the 14C-inulin peak, with its left-hand
slope slightly to the left of the radioactive curve (Fig. 1). This
difference was expected because some cleavage of terminal
sugar molecules occurs when '4C-cyanide is condensed with
inulin to produce inulin-'4COOH. Inulin mixtures containing
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Table 1. Characteristics of babies studied
Constant inulin infusion
After stopping
infusion
Final
Birth plasma Plasma
Patient Gestation weight Duration Rate inulin Interval inulin
no. Clinical course weeks grams days mg/kg hr ,ug/ml hours ,ag/ml
1 HMD; IPPV; died at 5 days 28 1175 3.0 15 320 — —
2 Healthy 28 850 6.8 18 450 10 115
3 Healthy 33 1250 2.1 14 285 15 30
4 HMD; IPPV for 4 days 27 960 9.0 18 230 11 50
5 HMD; IPPV; died at 21 days 29 1240 10.0 16 415 — —
Means 29 1093 6.2 16.2 340
Abbreviations: HMD, hyaline membrane disease; IPPV, intermittent positive pressure ventilation.
Fraction number
—
Fig. 1. Chromatograms of natural inulin alone (0) and with 5, 10, 15,
and 50% high molecular weight fraction added (*) '4C-inulin (
was run each time. Inulin with high molecular weight fraction is
). The PAH peak has been omitted for clarity.
some large molecular weight fractions all showed a hump on the
left-hand slope, those with greater amounts of the fraction
showing greater deviation from the natural inulin profile. There
was a close linear relationship between the percentage of high
molecular weight inulin present (y) and the value for S-'4C (y =
6.63 + 2.02(S-'4C); r = 0.999, P < 0.001). The S-'4C values
from the mixture containing only 5% of high molecular weight
inulin were significantly higher than those from natural inulin (P
<0.001 by t test; five runs in each group).
Chromatogram profiles and S-'4C values from the five paired
plasma and urine samples were indistinguishable from one
another (P > 0.9 by paired t test) and the same as the standard
aqueous natural inulin. It was not possible to evaluate the three
postinfusion plasma profiles in detail because the inulin concen-
tration in most fractions was so low, but the curves were
symmetrical and the peaks occurred in the usual place.
The curve produced by polyfructosan-S was broader and
displaced to the left compared to inulin (Fig. 2) suggesting a less
uniform and larger, effective molecular size.
Discussion. When inulin is infused constantly, the steady-
state concentration is determined by the inulin clearance and
the infusion rate. If the larger inulin molecules were not filtered
freely at the glomerulus, this would reduce their plasma clear-
ance and prolong their half-life, so that their final steady-state
concentration would be higher and reached more slowly. With
complete restriction to filtration, the larger molecules would
accumulate linearly with time.
Thus, in our study, if just 1% of the largest inulin molecules
was completely retained by the glomerulus, then an average
inulin infusion of 16.2 mg/kg/hr would lead to the accumulation
of 24 mg/kg of high molecular weight inulin over 6.2 days. This
would lead to a plasma concentration of 73 g/ml, assuming a
distribution volume of 330 ml/kg. Because the mean plasma
inulin level was 340 gIml, the high molecular weight fraction
would then have made up more than 20% of all the inulin (and
more than 50% in the most immature baby).
Even incomplete restriction to filtration would likely produce
a detectable change in the plasma inulin chromatogram. If 99%
of the molecules were filtered freely but only one fifth of the
effective filtration surface was available to the largest 1%, then
the steady-state plasma concentration of that fraction would be
five times higher than that of the rest of the molecules and
represent 5% of the total inulin. Therefore, the fact that we
found identical plasma and urine inulin profiles using a method
with which a sample containing 5% of high molecular weight
inulin can be identified confidently shows that there is no
effective restriction to filtration. This is confirmed further by
the postinlusion plasmas: After a delay of about 12 hr, most of
the freely filterable inulin would have been excreted, although
much of the poorly filtered inulin would remain and any skew in
the molecular weight profile would be exaggerated greatly. In
fact, the peak position remained unaltered after the inulin
concentration had fallen to 10 to 25% of its initial level.
Prolate molecules can be filtered more readily than spherical
ones of the same weight [3]. That the inulin molecule has been
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in even the most immature of human patients. The issue of
whether or not inulin is a suitable marker of glomerular filtra-
tion in kidney donors and transplant recipients [81 could be
clarified by a comparable study.
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Fig. 2. Chromatogram of polyfructosan-S ( ). 1C-inulin is repre-
sented by ( ). The PAH peak has been omitted for clarity.
characterized as a cylinder of up to 50 A in length and 20 A in
diameter whereas the polyfructosan molecule can be described
as a sphere of up to 46 A in diameter, probably accounts for our
gel-filtration chromatography findings. This also Suggests that
polyfructosan-S would be restrained by the glomerular filter
just as easily as inulin, although it has been implied that its
lower weight makes it a preferable marker for glomerular
filtration in rats [1] and preterm babies [7].
Our data provide direct evidence that inulin is filtered freely
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